首页 | 本学科首页   官方微博 | 高级检索  
     

符合线路单光子发射型计算机断层双时相显像鉴别病变性质的临床应用价值
引用本文:王荣福,张建华,张春丽,范岩,付占立,张旭初,胡怀湘,何晓坤,林景辉,郭凤琴,赵光宇,王彦福,田红. 符合线路单光子发射型计算机断层双时相显像鉴别病变性质的临床应用价值[J]. 北京大学学报(医学版), 2005, 37(3): 287-291
作者姓名:王荣福  张建华  张春丽  范岩  付占立  张旭初  胡怀湘  何晓坤  林景辉  郭凤琴  赵光宇  王彦福  田红
作者单位:北京大学第一医院核医学科,北京,100034;北京大学第一医院核医学科,北京,100034;北京大学第一医院核医学科,北京,100034;北京大学第一医院核医学科,北京,100034;北京大学第一医院核医学科,北京,100034;北京大学第一医院核医学科,北京,100034;北京大学第一医院核医学科,北京,100034;北京大学第一医院核医学科,北京,100034;北京大学第一医院核医学科,北京,100034;北京大学第一医院核医学科,北京,100034;北京大学第一医院核医学科,北京,100034;北京大学第一医院核医学科,北京,100034;北京大学第一医院核医学科,北京,100034
摘    要:目的:探讨氟[18F]-氟代脱氧葡萄糖(18F-FDG)双探头符合线路单光子发射型计算机断层(SPECT)双时相显像鉴别病变性质的临床应用价值.方法:30例病变性质不明的患者进行18F-FDG符合线路SPECT双时相显像,早期显像在注射18FDG后1 h进行,延迟显像分为2组,一组时间间隔为3.5 h,另一组时间间隔为4.5 h.结果:30例患者(1例患者行2次双时相显像)共检出48个病灶,其中恶性病变30个,良性病变18个,均经病理活检证实或临床随访确诊.用定性法分析,双时相显像的灵敏度96.7%,特异性83.3%,准确率91.7%,阳性预测值90.6%,阴性预测值93.8%.符合线路SPECT早期显像和CT检查的灵敏度、特异性、准确率、阳性预测值、阴性预测值分别为93.3%,72.2%,85.4%,84.8%,86.7%与76.9%,57.1%,70.0%,76.9%,57.1%.所有恶性病变(除1例假阴性病变外)延迟显像T/NT均明显升高(t=-3.071,P<0.01),而良性病变延迟显像与早期显像T/NT差异无统计学意义(t=0.398,P=0.695).结论:18F-FDG符合线路SPECT双时相显像有利于良、恶性病变鉴别,并有助于提高病变诊断的特异性及准确率.

关 键 词:体层摄影术  发射型计算机  单光子  肿瘤  氟放射性同位素
文章编号:1671-167X(2005)03-0287-05
修稿时间:2005-02-07

Study of clinical value of dual-phase imaging using single photon emission computed tomography with coincidence detection for differentiating benign from malignant lesions
WANG Rong-fu,ZHANG Jian-hua,ZHANG Chun-li,Fan Yan,FU Zhan-li,ZHANG Xu-chu,HU Huai-xiang,HE Xiao-kun,LIN Jing-hui,Guo Feng-qin,ZHAO Guang-yu,WANG Yan-fu,TIAN Hong. Study of clinical value of dual-phase imaging using single photon emission computed tomography with coincidence detection for differentiating benign from malignant lesions[J]. Journal of Peking University. Health sciences, 2005, 37(3): 287-291
Authors:WANG Rong-fu  ZHANG Jian-hua  ZHANG Chun-li  Fan Yan  FU Zhan-li  ZHANG Xu-chu  HU Huai-xiang  HE Xiao-kun  LIN Jing-hui  Guo Feng-qin  ZHAO Guang-yu  WANG Yan-fu  TIAN Hong
Affiliation:Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China. rongfu_wang2003@yahoo.com.cn
Abstract:Objective: To investigate the clinical value of dual-phase imaging of 18 F-fluoro-2-deoxy-D-glucose ( 18 F-FDG) using single photon emission computed tomography with coincidence detection (SPECT with coincidence) for differentiating benign and malignant lesions. Methods: Thirty patients with unknown lesions from June 2003 to March 2004 in our hospital were enrolled in this study. All patients underwent dual-phase imaging of 18 F-FDG SPECT with coincidence. The early images were obtained 60 min post injection. And the patients were divided into 2 groups, one receiving delayed scans at 210 min after 18 F-FDG injection and the other at 270 min. Lesion status was determined by pathologic findings or by clinical follow-up. Results: Forty-eight lesions (30 malignant and 18 benign lesions verified by pathologic findings or clinical follow-up) of 30 patients were detected by dual-phase imaging, in which there were 29 true positive results, 15 true negative, 3 false positive and 1 false negative. The sensitivity, specificity, accuracy, positive predictive value and negative predictive value of dual-phase imaging were 96.7%, 83.3%, 91.6%, 90.6%, and 93.8%, respectively. Those of early imaging and CT were 93.3%, 72.2%, 85.4%, 84.8%, 86.7% and 76.9%, 57.1%, 70.0%, 76.9%, 57.1%, respectively. The T/NT of all malignant lesions(except 1 false negative case) in delayed imaging were significantly increased (t=-3.071,P<0.01). However, there were no statistical differences in the T/NT of benign lesions (t=0.398,P=0.695) between early and delayed imagings. Conclusion: Dual-phase imaging of FDG SPECT with coincidence provides benefit for differentiating benign and malignant lesions.
Keywords:Tomography   emission-computed   single-photon  Neoplasms  Fluorine radioisotopes
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号